EMEA-001943-PIP03-20

Table of contents

Key facts

Invented name
Ultomiris
Active substance
ravulizumab
Therapeutic area
Neurology
Decision number
P/0230/2021
PIP number
EMEA-001943-PIP03-20
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of myasthenia gravis
Route(s) of administration
Intravenous use
Contact for public enquiries
Alexion Europe SAS

E-mail: pip.enquiries.eu@alexion.com
Tel: +33 147100615

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating